From: Quantifying late gadolinium enhancement on CMR provides additional prognostic information in early risk-stratification of nonischemic cardiomyopathy: a cohort study
HR
95% CI
p-value
Model (forward stepwise)
LGE extent, % LV volume
1.027
1.009 - 1.044
0.003
Sustained VT
4.793
1.428 - 16.087
0.011
LVEF (CMR), %
0.962
0.929 - 0.997
0.034